UNION PHARMA SECRETARY

Regulation largest barrier in pharma; Indian cos should focus on quality: Official

Indian pharmaceuticals have scale, cost and quality advantages which have enabled companies to make a mark and garner market share in all countries across the world. Cost competitiveness cannot be the single factor ensuring continued growth for any industry or sector.